Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Eur Urol Focus. 2016 Jun 16;3(4-5):457–466. doi: 10.1016/j.euf.2016.05.009

Fig. 1.

Fig. 1

Prostate tissue microarray cores (a, d, g, j) corresponding to patients who experienced (a–f) recurrence and (g–l) no recurrence. Automated segmentation defines nuclear boundaries and locations from tumor and benign field tissue cores, characterizing (b, e, h, k) nuclear shape and (c, f, i, l) nuclear subgraphs describing local nuclear architecture.